Literature DB >> 11132792

Neuropsychological functioning in patients with asymptomatic congenital cytomegalovirus infection.

R O Temple1, R F Pass, T J Boll.   

Abstract

Congenital cytomegalovirus (CMV) infection has an affinity for the central nervous system and has been implicated in a variety of neurological impairments. Analysis of cognitive functioning in children with asymptomatic congenital CMV infection, however, has revealed no general intellectual deficits. The present study was designed to explore neuropsychological test performance in these children, compared with healthy control subjects, providing data from more sensitive measures of neurocognitive functioning. The sample consisted of 109 children diagnosed with asymptomatic congenital CMV infection and 173 control subjects who were compared on tests measuring various aspects of perceptual and motor functioning, memory, problem solving, and traditional intelligence measures. Young (41NDASH6 yr) control patients performed significantly better on the Full-Scale but not the Verbal or Performance intelligence quotient (IQ) measures than patients with asymptomatic congenital CMV infection, without accompanying consistent neuropsychological performance differences. However, no IQ or neuropsychological differences were found between groups of older children. The present study adds to the existing literature finding no reliable, lasting differences in IQ scores and adds to our knowledge by finding no reliable, lasting differences in neuropsychological test performance.

Entities:  

Mesh:

Year:  2000        PMID: 11132792     DOI: 10.1097/00004703-200012000-00003

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  8 in total

Review 1.  Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?

Authors:  Michael J Cannon; Paul D Griffiths; Van Aston; William D Rawlinson
Journal:  Rev Med Virol       Date:  2014-04-24       Impact factor: 6.989

2.  Apparent Diffusion Coefficient Value Changes and Clinical Correlation in 90 Cases of Cytomegalovirus-Infected Fetuses with Unremarkable Fetal MRI Results.

Authors:  D Kotovich; J S B Guedalia; C Hoffmann; G Sze; A Eisenkraft; G Yaniv
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-18       Impact factor: 3.825

3.  Intelligence and Academic Achievement With Asymptomatic Congenital Cytomegalovirus Infection.

Authors:  Adriana S Lopez; Tatiana M Lanzieri; Angelika H Claussen; Sherry S Vinson; Marie R Turcich; Isabella R Iovino; Robert G Voigt; A Chantal Caviness; Jerry A Miller; W Daniel Williamson; Craig M Hales; Stephanie R Bialek; Gail Demmler-Harrison
Journal:  Pediatrics       Date:  2017-11       Impact factor: 7.124

4.  The Natural History and Rehabilitative Outcomes of Hearing Loss in Congenital Cytomegalovirus: A Systematic Review.

Authors:  Kyle T Fletcher; Erin M Wolf Horrell; John Ayugi; Catherine Irungu; Maria Muthoka; Liza M Creel; Cathy Lester; Matthew L Bush
Journal:  Otol Neurotol       Date:  2018-08       Impact factor: 2.311

Review 5.  Neurodevelopment: The Impact of Nutrition and Inflammation During Early to Middle Childhood in Low-Resource Settings.

Authors:  Chandy C John; Maureen M Black; Charles A Nelson
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

Review 6.  Long-term neuropsychological deficits after central nervous system infections despite adequate therapy.

Authors:  Roland Nau; Holger Schmidt
Journal:  J Neurol       Date:  2007-05       Impact factor: 6.682

7.  Differences in cognitive functions between cytomegalovirus-infected and cytomegalovirus-free university students: a case control study.

Authors:  Veronika Chvátalová; Blanka Šebánková; Hana Hrbáčková; Petr Tureček; Jaroslav Flegr
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

8.  Trends in hospitalizations for diagnosed congenital cytomegalovirus in infants and children in Australia.

Authors:  Holly Seale; Robert Booy; C Raina MacIntyre
Journal:  BMC Pediatr       Date:  2009-01-26       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.